Skip to main content Skip to section navigation Skip to footer

Lucid Diagnostics Inc.

  • Investors
  • Company

    • About Us
    • Leadership
    • Medical Advisory Board
    • Careers
  • Products

    • EsoCheck
    • EsoGuard
  • Clinical

    • BETRNet
    • References
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 14, 2023 7:09pm EDT

PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results

Mar 13, 2023 6:21pm EDT

Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial Results

Mar 03, 2023 8:15am EST

PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023

Mar 03, 2023 8:15am EST

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023

Feb 15, 2023 8:30am EST

Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event

Jan 17, 2023 4:05pm EST

PAVmed and Lucid Diagnostics Provide Strategic Business Update

Jan 11, 2023 8:00am EST

PAVmed and Lucid Diagnostics to Provide Strategic Business Update

Dec 22, 2022 8:25am EST

PAVmed Partners with Novosound on Ultrasound Imaging Technology

Dec 15, 2022 8:25am EST

PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform

Dec 08, 2022 8:25am EST

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • arrow_forward
rss_feedNews RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

One Grand Central Place, Suite 4600
New York, NY 10165

Email: info@LucidDX.com

212-949-4319

  • White Twitter Icon
  • White LinkedIn Icon
  • ©2023 Lucid Diagnostics Inc. All Rights Reserved.
  • Privacy Policy